To evaluate the lytic capacity of TILT-517 alone (structure can be found in Figure 2A) or in combination with ICIs, tumor single-cell suspensions from these 9 patients were treated ex vivo with either TILT-517 and/or either anti-PD-1 or anti-PD-L1 (Figure 2B). Here, CD274 is linked to neoplasm.